Evidence-led coverage of peptide medicines, metabolic health, GLP-1 therapies, and longevity-therapeutics claims.
A scientific claim decoder for separating human outcomes from biomarkers, animal evidence, mechanisms, and marketing around GLP-1s, peptides, and longevity therapies.
How to distinguish accountable GLP-1 care from counterfeit products, research-use peptides, illegal online sellers, and poorly disclosed compounded offers.
A seven-rung evidence ladder for separating FDA labels, clinical trials, real-world evidence, sponsor reports, testimonials, and unapproved GLP-1 sales claims.
How to distinguish published trial evidence, regulatory review, FDA approval, and unapproved sales in the fast-moving metabolic-drug pipeline.
Eight source-backed questions for checking an online GLP-1 provider’s clinical accountability, medication category, pharmacy, follow-up, claims, price, and commercial influence.
A plain-language guide to affiliate, paid-placement, medication-category, price, and evidence disclosures on GLP-1 pages.
A source-backed guide to the six categories commonly blurred together in peptide marketing: FDA-approved drugs, compounded medication, investigational drugs, research-use products, longevity protocols, and supplements.
A source-backed guide to checking clinician responsibility, state authority, pharmacy identity, follow-up, escalation, and continuity in online GLP-1 care.
Six hard-stop safety signals and six serious caution flags to check before trusting an online GLP-1 medication offer.
What compounded GLP-1 medication means, why it is not an FDA-approved generic, how shortage rules changed, and what consumers should verify.
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.